Word

BELAMOV

Status

Dead

Status Code

606

Status Date

Monday, September 14, 2015

Serial Number

85835253

Mark Type

4000

Filing Date

Tuesday, January 29, 2013

Published for Opposition

Tuesday, June 18, 2013

Abandoned Date

Monday, September 14, 2015

Trademark Owner History

Glaxo Group Limited - Owner At Publication

Classifications

5 (Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

The wording "BELAMOV" has no meaning in a foreign language.

Trademark Events

Sep 14, 2015

Abandonment Notice Mailed - No Use Statement Filed

Sep 14, 2015

Abandonment - No Use Statement Filed

Jun 22, 2015

Teas Change Of Correspondence Received

Jan 29, 2015

Notice Of Approval Of Extension Request E-Mailed

Jan 28, 2015

Extension 3 Granted

Jan 15, 2015

Extension 3 Filed

Jan 15, 2015

Teas Extension Received

Aug 14, 2014

Notice Of Approval Of Extension Request E-Mailed

Aug 13, 2014

Extension 2 Granted

Jul 14, 2014

Extension 2 Filed

Aug 7, 2014

Case Assigned To Intent To Use Paralegal

Jul 14, 2014

Teas Extension Received

Feb 13, 2014

Notice Of Approval Of Extension Request E-Mailed

Feb 11, 2014

Extension 1 Granted

Feb 11, 2014

Extension 1 Filed

Feb 11, 2014

Teas Extension Received

Aug 13, 2013

Noa E-Mailed - Sou Required From Applicant

Jun 18, 2013

Official Gazette Publication Confirmation E-Mailed

Jun 18, 2013

Published For Opposition

May 29, 2013

Notification Of Notice Of Publication E-Mailed

May 13, 2013

Electronic Record Review Complete

May 10, 2013

On Hold - Electronic Record Review Required

May 6, 2013

Approved For Pub - Principal Register

May 2, 2013

Assigned To Examiner

Mar 20, 2013

Applicant/Correspondence Changes (Non-Responsive) Entered

Mar 20, 2013

Teas Change Of Owner Address Received

Feb 4, 2013

New Application Office Supplied Data Entered In Tram

Feb 1, 2013

New Application Entered In Tram